Cargando…
Current Status and Future Targeted Therapy in Adrenocortical Cancer
Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. The current treatment standards include complete surgical resection for localized resectable disease and systemic therapy with mitotane alone or in combination with etoposide, doxorubicin, and cisplatin in patients with advan...
Autores principales: | Alyateem, George, Nilubol, Naris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957049/ https://www.ncbi.nlm.nih.gov/pubmed/33732213 http://dx.doi.org/10.3389/fendo.2021.613248 |
Ejemplares similares
-
New Therapies for Advanced Thyroid Cancer
por: Laha, Diprajan, et al.
Publicado: (2020) -
Editorial: Molecular Mechanisms in Cancer Endocrinology With Clinical Implications
por: Nilubol, Naris
Publicado: (2022) -
Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
por: Michael, Nicholas, et al.
Publicado: (2022) -
SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019) -
Adrenocortical carcinoma and pulmonary embolism from tumoral extension
por: Shekhar, Skand, et al.
Publicado: (2019)